Células dendríticas (DCs) participam tanto da geração da resposta imune adaptativa como na manutenção da tolerância. O veneno da cascavel Crotalus durissus terrificus, sua principal toxina, crotoxina (CTX) e sua subunidade CB (fosfolipase A2), apresentam efeito supressor sobre o sistema imunológico. Neste trabalho foi avaliado o efeito da CTX e CB sobre a ativação/função das DCs e consequente indução de resposta adaptativa específica anti-Ovalbumina (OVA). Primeiramente, foi verificada a eficiência do processo de maturação das DCs incubadas com OVA associada ao LPS. Os resultados obtidos nesse modelo in vitro mostraram que a CTX e CB inibiram a maturação das DCs estimuladas com OVA + LPS, caracterizada por menor expressão de moléculas coestimuladoras, MHC-II e secreção de citocinas pró-inflamatórias. Em contraste, a CTX e CB induziram maior expressão de ICOS-L, PDL1/2 nas DCs incubadas com OVA + LPS assim como a expressão de RNAm para IL-10 e TGF-β. Além disso, ambas as toxinas foram capazes de aumentar a expressão de PDL1, mas não de ICOS-L ou PDL-2 em DCs. Com relação ao mecanismo envolvido no efeito da CTX e CB sobre as DCs, os resultados mostraram o envolvimento dos receptores peptídeo-formil (FPRs) e a via da 5-Lipoxigenase nesse processo. Sobre a imunidade adaptativa, os resultados mostraram menor proliferação de células TCD3+ ou TCD4+ obtidas de animais imunizados com OVA quando co-cultivadas com DCs incubadas com ConA ou OVA + LPS na presença de CTX ou CB. A diferenciação de células Th1 e Th2 foi inibida pela adição de CTX ou CB nas co-culturas com DCs estimuladas com LPS. No entanto, verificou-se aumento da população Treg nas co-culturas de células CD4+ e DCs incubadas com LPS + CTX ou CB em comparação com DCs estimuladas somente com LPS. A CTX e CB inibiram a diferenciação de células CD4+ Tbet+ e CD4+Gata3+ nas co-culturas de TCD4+ purificados de animais DO 11.10 com DCs estimuladas com OVA + LPS. No entanto, apenas a CTX foi capaz de induzir aumento da porcentagem de células CD4+CD25+FoxP3+. Em experimentos in vivo, foi observada menor proliferação e secreção de IL-2 e IFN nas culturas de células de camundongos imunizados com OVA que receberam CTX ou CB quando estimuladas com OVA em comparação com o observado nas culturas de células de camundongos imunizados com OVA. CTX e CB administradas in vivo em camundongos imunizados com OVA também inibiram a porcentagem de células CD4+IFN+, CD4+IL-4+ e promoveram aumento da população CD4+IL-10+ em comparação com o obtido em camundongos imunizados somente com a OVA. Em relação à imunidade humoral, a produção de anticorpos IgG1 e IgG2a anti-OVA também foi inibida em camundongos imunizados com OVA que receberam a CTX ou CB. Além disso, a reação de hipersensibilidade do tipo tardio foi suprimida somente em camundongos imunizados com OVA e que receberam a CTX. Estes dados demonstram que a CTX e CB exercem efeito regulador sobre o sistema imune inato e adaptativo e os FPRs bem como a via da 5-lipoxigenase estão envolvidos nessa ação imunomoduladora. / Dendritic cells (DCs) are involved in both the generation of the adaptive immune response and maintenance of the tolerance. The Crotalus durissus terrificus rattlesnake venom, its main toxin, crotoxin (CTX) and CB (phospholipase A2) subunit have suppressive effect on the immune system. In this work it was analyzed the effect of CTX and its CB subunit on the activation/function of DCs and consequent induction of anti-ovalbumin immune response. Firstly, the efficiency of the DCs maturation incubated with OVA associated with LPS was verified. Following, the results obtained in this in vitro model showed that CTX and CB inhibited the maturation of DCs stimulated with OVA + LPS, characterized by lower expression of costimulatory, MHC-II molecules on DCs as well as secretion of proinflammatory cytokines. In contrast, CTX and CB induced an enhancement of ICOS-L, PDL1/2 expression on DCs incubated with OVA, +LPS as well as the expression of IL-10 and TGF-ß RNAm. In addition, both toxins were able to increase the expression of PDL1, but not ICOS-L or PDL-2, on DCs. Regarding the mechanism involved in the effect of CTX and CB on DCs, the results showed the involvement of the formyl-peptide receptors (FPRs) and the 5-Lipoxygenase pathway in this process. On adaptive immunity, the results showed lower proliferation of TCD3+ or TCD4+ cells obtained from mice immunized with OVA when co-cultured with DCs incubated with ConA or OVA + LPS in the presence of CTX or CB. The differentiation of Th1 and Th2 cells were inhibited by the addition of CTX or CB in co-cultures with DCs stimulated with LPS. However, it was verified increased Treg population in co-culture of CD4+cells and DCs incubated with LPS plus CTX or CB compared with DCs LPS-stimulated. CTX and CB inhibited the differentiation of of CD4+Tbet+ and CD4+Gata 3+ cells in co-cultures of TCD4+ purified from DO11.10 mice with DCs stimulated with OVA + LPS. However, only CTX was able to increase the percentage of CD4+CD25+FoxP3+ cells. In in vivo experiments, it was observed lower proliferation and IL-2 and IFN secretions in cell cultures of mice immunized with OVA that received CTX or CB incubated with OVA compared with those observed in cell culture of OVA-immunized mice. The administration of CTX and CB in vivo in mice immunized with OVA also inhibited the percentage of CD4+IFN+, CD4+IL-4+ cells and increased the CD4+IL-10+ population compared with those observed in mice immunized with OVA. In relation to the humoral immunity, the production of anti-OVA IgG1 and IgG2a antibodies was also inhibited in mice immunized with OVA that received CTX or CB. In addition, the delayed hypersensitivity reaction (DTH) was also diminished in mice immunized with OVA that received the CTX. These data demonstrate that CTX and CB exert regulatory effect on innate and adaptive immune system and that FPRs as well as the 5-lipoxygenase pathway are involved in this immunomodulatory activity.

Die Veraenderungen des Immunsystems mit zunehmendem Alter, Immunseneszenz genannt, resultieren in erhoehter Infektanfaelligkeit. Infolge dessen leiden aeltere Menschen unter haeufigeren und schwerer verlaufenden Infekten, Autoimmunerkrankungen und vermindertem Impfschutz. Immunseneszenz entsteht nicht nur aufgrund chronologischen Alterns, sondern wird auch durch andere teils ungeklaerte Faktoren verursacht. Cytomegalievirus (CMV) ist ein Herpesvirus, dass in immunkompetenten Menschen lebenslang persistiert. Infolge chronischer Immunaktivierung traegt CMV zur beschleunigten Immunseneszenz bei. In dieser Arbeit wurden die Alters- und CMV-induzierten Veraenderungen in humanen T-Zellen analysiert. Dafuer wurden PBMC von 50 gesunden Spendern in drei verschiedenen Altersgruppen antigenspezifisch (CMV-Proteine pp65 und IE1 und protein purified derivate von Mycobacterium tuberculosis (PPD)) und polyklonal (OKT3) in vitro stimuliert. Ein 11-Farben-Panel wurde etabliert, um die simultane Expression der Differenzierungsmarker CD45RA und CD27 und der Aktivierungsmarker CD40L, IFNg, IL2 und TNF auf T-Zellen durchflusszytometrisch zu untersuchen. Die Ergebnisse dieser Arbeit zeigten, dass die antigenabhaengige Differenzierung der Gedaechtnis-T-Zellen mit zunehmendem Alter und CMV-Infektion zunahm. Die Differenzierung der Gedaechtnis-T-Zellen in CMV-positiven Spendern war ausserdem mit der Antwortgroesse gegen pp65 korreliert. Die pp65-spezifische, aber nicht die IE1-spezifische polyfunktionale T-Zell-Antwort nahm mit zunehmendem Alter der Probanden zu. Zusammenfassend kann gesagt werden, dass CMV einen grossen Einfluss auf das Immunsystem gesunder Individuen hat. Die Differenzierung der Gedaechtnis-T-Zellen ist nicht nur abhaengig von der Infektion mit CMV, sondern auch davon, wie das Immunsytem auf CMV reagiert. Polyfunktionale CMV-spezifische T-Zellen, die wahrscheinlich CMV kontrollieren, sind vorhanden und werden nicht von dysfunktionalen T-Zellen im Alter verdraengt. / Ageing of the immune system, also called immunosenescence, is a phenomenon that leads to increased susceptibility to infections in elderly people. Persistent cytomegalovirus (CMV) infection induces strong T cell responses in humans and is thought to be one of the driving forces of immunosenescence. In this work CMV-induced alterations in the T cell compartment of human individuals were analysed in terms of frequencies and absolute numbers per ml blood. Peripheral blood mononuclear cells (PBMC) from 50 donors in three different age groups were stimulated in vitro and examined for the phenotypic markers CD45RA and CD27 and the effector molecules CD40L, IFNg, IL2 and TNF by polychromatic flow cytometry. The frequency of responding polyfunctional T cells to stimulation with OKT3 or CMV peptide pools phosphoprotein 65 (pp65) or immediate-early protein1 (IE1) increased with the age of the donor. The memory subset distribution differed between CMV-seronegative and CMV-seropositive donors and was correlated with the response size in the CMV-seropositive group. Polyfunctional T cells expressed quantitatively and qualitatively more activation marker on a per cell level than monofunctional cells and therefore appeared to be more effective. Furthermore, polyfunctional T cells expressed reduced amounts of surface CD3, CD4 and CD8 compared to monofunctional or non-responding T cells. In summary, the results indicate that CMV has a significant influence on the immune system of healthy people. The memory subset composition of the entire T cell compartment depends on how the immune system responds to CMV (large or small responses) rather than the presence or absence of infection. Irrespectively of response size or age a robust population of polyfunctional CMV-specific T cells is present and may be in control of CMV.

Die Invasion von Leukozyten in das zentrale Nervensystem (ZNS) ist ein wesentlicher Bestandteil bei der Pathogenese von Hirnverletzungen sowie akuten und chronischen Entzündungsvorgängen im Gehirn. Mikrogliazellen, die überwiegende Population immunkompetenter Zellen des ZNS, stellen die erste Verteidigungslinie im Hinblick auf Verletzungen und Erkrankungen des Gehirns dar. Im Rahmen vieler neurodegenerativer Erkrankungen wird die Zerstörung von Neuronen, aber auch die kollaterale Gewebsschädigung auf die Aktivierung der Mikrogliazellen zurückgeführt. Die vorliegende Arbeit beschreibt erstmalig einen regulatorischen Aktivierungszustand der Mikroglia (CD40dimCD86dimIL-10high), der zur Induktion regulatorischer Foxp3+ T-Zellen (Treg) führt. Die Stabilität und funktionelle Aktivität Mikroglia-induzierter Treg konnte sowohl in vitro als auch in vivo gezeigt werden. In vitro inhibierten sie die Proliferation antigen-spezifischer Effektorzellen, in vivo führte ein adoptiver Transfer der regulatorischen T-Zellen zur Abmilderung des Krankheitsverlaufes experimentell induzierter, autoimmuner Enzephalomyelitis (EAE). Mikrogliazellen unterstützten sowohl die Proliferation bereits ausgebildeter regulatorischer T-Zellen als auch deren Differenzierung aus naiven T-Zellen. Die Induktion regulatorischer T-Zellen durch Mikroglia war Major Histocompatibility Complex (MHC)-II-abhängig und antigenspezifisch. Für Untersuchungen zur in vivo Relevanz wurden MHC-II-chimäre Mäuse generiert und eine Läsion im entorhinalen Kortex gesetzt. Fehlte MHC-II in ZNS-residenten Zellen, wurden weniger regulatorische T-Zellen pro Leukozyt in die lädierten Hemispheren rekrutiert. Zusammenfassend demonstrieren diese Ergebnisse das Modulationspotential von Mikrogliazellen auf die CD4+ T-Zellantwort. Die Mikroglia-induzierte Differenzierung und Proliferation von Foxp3+ regulatorischen T-Zellen ist ein möglicher Mechanismus der Regulation von Entzündungsvorgängen im ZNS durch Mikrogliazellen. / The invasion of leukocytes into the central nervous system (CNS) is a key event in the pathogenesis of CNS injury and acute or chronic inflammatory neurological diseases. However, regulatory mechanisms of local innate immune responses that limit CNS inflammation are only poorly understood. Microglia are the predominant innate immune cells of the brain and present the first line of defence in CNS injury or disease. In the context of neurodegenerative disease, microglia activation accounts for collateral tissue damage and neurodestruction. This thesis for the first time describes a regulatory microglia phenotype (MHCII+CD40dimCD86dimIL-10high) that induced a strong Foxp3+ regulatory T cell (Treg) response. Microglia-induced Treg cells were stable and functionally active in vitro by inhibiting antigen-specific proliferation of effector T cells and in vivo, by attenuating experimental autoimmune encephalomyelitis (EAE) disease course after adoptive transfer. The data also suggested that regulatory microglia can mediate both, proliferation of Foxp3+ Treg cells and de novo differentiation from naive CD4+ T cells. Microglia-mediated Treg induction was proven to be MHCII and antigen-dependent. Using entorhinal cortex lesion (ECL) as a brain injury mouse model, diminished Foxp3+ Treg cell recruitment per infiltrated leukocyte in chimeric mice lacking MHCII specifically in the CNS was demonstrated, indicating in vivo relevance of antigen presentation by brain resident cells. Taken together, these findings demonstrate that microglial cells can directly modulate CD4+ T cell responses by regulating molecule levels for efficient antigen presentation and levels of secreted cytokines and chemokines. Microglia-mediated differentiation and proliferation of Foxp3+ Treg cells can be one of the mechanisms how microglia contribute to local immune homeostasis and limit CNS inflammation.

No presente trabalho, descrevemos na saliva do mosquito Aedes aegypti uma atividade de indução de morte de linfócitos caracterizada pela rápida exposição de fosfatidilserina na superfície celular, incorporação de iodeto de propídio, diminuição do tamanho celular, perda da expressão de CD62L e seletividade para linfócitos naïve. A molécula responsável por essa atividade foi identificada pelo fracionamento do extrato da glândula salivar (EGS) do mosquito por HPLC e espectrometria de massas. O RNA mensageiro que codifica essa molécula está presente abundantemente em fêmeas de A. aegypti mas não em machos, sugerindo sua participação no repasto sanguíneo. RNA de interferência foi utilizado para silenciar o gene responsável por essa atividade em fêmeas de A. aegypti e o EGS desses mosquitos perdeu a capacidade de induzir a morte de linfócitos, confirmando ser essa a molécula responsável pela atividade. Em conclusão, o presente trabalho identifica uma nova molécula presente na saliva de A. aegypti com atividade rápida, potente e seletiva sobre linfócitos. / In the present work, we described in the saliva of Aedes aegypti mosquito an activity of cell death induction for lymphocytes characterized by fast phosphatidylserine exposure in cell surface, incorporation of propidium iodide, cell shrinkage, loss of CD62L expression, and selectivity for naïve lymphocytes. The molecule responsible for this activity was identified by fractionation of mosquito salivary gland extract (SGE) by HPLC and mass spectrometry. The messenger RNA that codifies this molecule is abundantly present in A. aegypti females but not in males, suggesting its role in blood-feeding. RNA interference was employed to silence the gene responsible for this activity in A. aegypti females and the SGE of these mosquitoes lost the ability to induce lymphocyte death, confirming that this is the molecule responsible for the activity. In conclusion, this work identifies a new molecule from A. aegypti saliva with a fast, potent and selective activity on lymphocytes.

Dans cette étude, nous avons tenté de décrypter les mécanismes reliant l’augmentation de lymphocytes infiltrant les tumeurs (LIT) T CD8+ et un pronostic clinique défavorable dans le cancer du rein à cellules claires (ccRCC). Pour cela, nous avons déterminé 1) la relation entre le pronostic associé à l'expression d’immune checkpoints et l’infiltrat de cellules dendritiques (DC) et de LT CD8+ et 2) les caractéristiques phénotypiques des LIT T CD8+. L’expression des immune checkpoints a été déterminée par immunohistochimie dans une cohorte de 135 ccRCC. Nous avons constaté que les densités des cellules exprimant CD8, PD-1 et LAG-3 sont corrélées, et associées à une diminution de PFS et OS. Egalement, les patients dont les tumeurs présentent des densités élevées de cellules PD-1+ et PD-L1 et/ou PD-L2 +, ont le taux de survie le plus faible. Des densités élevées de DC immatures isolées dans le stroma tumoral sont associées à une forte expression d’immune checkpoints et à un faible taux de survie chez ces patients. En revanche, les patients présentant un taux de survie prolongé ont une densité élevée de lymphocytes CD8+, des DC matures au sein de structures lymphoïdes tertiaires, ainsi qu’une faible expression d’immune checkpoints. Nous avons analysé les LIT T CD8+ chez 21 patients ccRCC par Cytométrie de Flux. On a trouvé un groupe de patients (8/21) dont les tumeurs sont caractérisées par la surexpression de marqueurs inhibiteurs (PD1 et TIM3) et de d'activation (CD69 et CD38), par l'expansion des cellules T CD8 + mémoires effectrices et un plus grand potentiel d’agressivité. En résumé, nous avons démontré qu’une densité élevée de LIT T CD8+ dans les ccRCC est accompagnée d’une forte expression d’immune checkpoints et d’une réponse immunitaire mal coordonnée dans un sous-groupe de tumeurs agressives. / To decipher the potential mechanisms linking increased CD8+ T cell infiltration with an adverse clinical outcome in ccRCC, in this study we determined: 1) the prognosis associated with the expression of immune checkpoints and its coordination with dendritic cell (DC) and CD8+ cell infiltration, and 2) the phenotypic traits of CD8+ tumor infiltrating lymphocytes. The prognosis associated with CD8+ and DC infiltrations, in addition to the expression of immune checkpoints were investigated in a cohort of 135 ccRCC by quantitative immunohistochemistry. We found that the densities of CD8+, PD-1+ and LAG-3+ cells were closely correlated, and independently associated with decreased PFS and OS. In addition, patients whose tumors presented both high densities of PD-1+ cells and PD-L1+ and/or L2+ tumor cells, displayed the worst clinical outcome. High densities of immature DC isolated in the tumour stroma were associated with high expression of immune checkpoints and patients’ poor clinical outcome. In contrast, the presence of mature DC within Tertiary Lymphoid Structures identified, among the tumours with high CD8+-TIL densities, those with low expression of immune checkpoints and prolonged survival. We also investigated the phenotype of freshly isolated CD8+TIL in 21 ccRCC by flow cytometry. We found a group tumors (8/21) characterised by the over-expression of inhibitory (PD-1 and TIM-3) and activation markers (CD69 and CD38), the expansion of the effector memory cell subpopulation (CCR7-CD45RA-), and a trend toward more aggressive features. In summary, we demonstrated that the infiltration with CD8+ TIL in ccRCC is accompanied by the enhanced expression of immune checkpoints and a poorly coordinated immune response in a subgroup of aggressive tumors.

INTRODUÇÃO: Células-tronco mesenquimais da geleia de Wharton (GW-CTM) exibem a capacidade de modular a resposta das células T e geralmente esses efeitos imunomoduladores são anti-inflamatórios. Devido ao seu potencial imunossupressor, as CTM emergiram recentemente como uma ferramenta promissora para terapia celular. No entanto, essas células têm uma vida útil limitada in vitro, com redução progressiva da sua capacidade de autorrenovação e parada irreversível do ciclo celular. O resultado deste processo é a perda da funcionalidade das CTM, o que limita a sua utilização para fins terapêuticos. Pouco se sabe sobre a variabilidade individual das amostras de GW-CTM e como isso poderia afetar sua expansão in vitro, seu potencial imunomodulador e o processo de envelhecimento. Neste estudo, avaliamos o perfil de citocinas imunomoduladoras e a capacidade das GW-CTM inibir a proliferação de células T durante o processo de senescência replicativa para determinar se a resposta esperada é afetada. MÉTODOS: GW-CTM foram cultivadas até a senescência replicativa ser atingida; as amostras foram coletadas numa fase inicial (passagem 5), numa etapa intermediária (passagem 15) e na senescência replicativa (passagem geralmente entre 20 e 25) para análise do perfil basal de moléculas imunomoduladoras. GW-CTM foram cocultivadas com amostras de duas células mononucleares de sangue periférico (PBMC), obtidas de doadores de plaquetas saudáveis. PBMC foi estimulado com fitohemaglutinina (PHA) durante 72 horas e cocultivado com três amostras de GW-CTM diferentes para medir a supressão da proliferação das células T. Os experimentos foram realizados utilizando as passagens P5 e P10. As análises foram feitas por PCR em tempo real, western blot e citometria de fluxo. RESULTADOS: Nossos resultados mostram que a expressão gênica e a secreção de moléculas imunomoduladoras variam entre amostras de GW-CTM, sem padrão específico. Em cocultura, todas as GW-CTM foram capazes de inibir a proliferação de células T CD3+ ativadas por mitogéno, embora em diferentes graus. E cada PBMC respondeu à cocultura com um nível diferente de inibição. Além disso, o perfil imunomodulador de todas as GW-CTM foi essencialmente mantido, mesmo após várias passagens. CONCLUSÃO: Nossos dados indicam que cada GW-CTM exibe um comportamento único, diferindo nos padrões de expressão e secreção de citocinas e capacidade imunomoduladora. Essa variabilidade intrínseca entre amostras pode influenciar a eficácia de GW-CTM quando utilizadas em terapia celular / INTRODUCTION: Wharton\'s jelly mesenchymal stem cells (WJ-MSC) exhibit the ability to modulate T cell responses and these immunomodulatory effects are usually anti-inflammatory. Due to their immunosuppressive potential, MSC have recently emerged as a promising tool for cell therapy. However, MSC have a limited lifespan in vitro, with a progressive reduction in their capacity for selfrenewal leading to irreversible arrest of cell division. The result of this process is the loss of stem cell functionality, which limits its use for therapeutic purposes. Information on the variability of individual cell samples impacting upon in vitro expansion, immunomodulatory potential, and aging processes is still lacking. In this study, we evaluated the immunomodulatory cytokine profile and capacity to inhibit T cell proliferation of WJ-MSC progressing to replicative senescence to determine if the expected response is affected. METHODS: WJ-MSC were cultured until replicative senescence was reached and the samples were collected at an early stage (passage 5), at an intermediate stage (passage 15), and in replicative senescence (passage generally between 20 and 25) to analyze the basal profile of immunomodulatory molecules. WJ-MSC were co-cultured with samples from the same two peripheral blood mononuclear cells (PBMC), obtained from healthy platelet donors. PBMC were stimulated with phytohemagglutinin (PHA) for 72 hours and tested against 3 different WJ-MSC to measure suppression of T cell proliferation. The experiments were performed using passages P5 and P10. Analyses were done by real-time PCR, western blot, and flow cytometry. RESULTS: Our results show that gene expression and secretion of immunomodulatory molecules varied among WJ-MSC samples with no specific pattern discernible. In co-culture all WJ-MSC were capable of inhibiting mitogen-activated CD3+ T cell proliferation, although to different extents and each PBMC responded with its unique level of inhibition. In addition, the immunomodulatory profile of each WJ-MSC sample was essentially maintained even after several passages. CONCLUSION: Our results indicate that each WJMSC displays a unique behavior, differing in patterns of cytokine mRNA expression and immunomodulatory capacity. The intrinsic variability between samples may influence the effectiveness of WJ-MSC when employed therapeutically

O Zika vírus (ZIKV) pertence à família flaviviridae que inclui espécies transmitidas principalmente por mosquitos Aedes sp. No Brasil, casos de microcefalia fetal foram associados à infecção congênita por ZIKV. Vários mecanismos de imunorregulação operantes durante a gestação como a inflamação gerada e resposta antiviral são vitais para o entendimento da infecção congênita do ZIKV. Desta forma, é proposto avaliar se a inflamação via ativação do receptor Toll-like 4 (TLR4-LPS) em vilos placentários humanos e em modelo murino interfere na infecção por ZIKV. Para isso, explantes de vilos placentários humanos de 3o trimestre foram ativados com LPS e posteriormente infectados com ZIKV. Nossos achados mostram que a ativação com LPS é capaz de aumentar a replicação de ZIKV em vilos placentários e de elevar a atividade enzimática da lactato desidrogenase, indicativo de ativação celular. A replicação viral foi inibida com o tratamento dos explantes com um antioxidante, Naringenina, mostrando potencial terapêutico. A ativação placentária com LPS inibiu a via IRF-3, diminuindo a atividade antiviral e aumentando a clivagem proteica do componente da via de autofagia LC3, sendo que estes mecanismos podem estar relacionados com o aumento da replicação viral. Em paralelo, foi detectado aumento da produção de citocinas inflamatórias e hiperplasia das células de Hofbauer nos explantes inflamados e infectados, indicando que estes macrófagos fetais podem ser um nicho de replicação viral. Em modelo murino, evidenciamos que a inoculação intravaginal de LPS em fêmeas prenhas previamente à infecção com ZIKV é capaz de promover o aumento de carga viral no cérebro das mães e da prole, com agravamento do quadro de microcefalia nos fetos. Em conjunto, os dados mostram que em modelo de explante placentário humano e, in vivo , em camundongos, a inflamação é fator predisponente da replicação do ZIKV. As estratégias imunomoduladoras mostram potencial terapêutico, atenuando a resposta inflamatória e a diminuição da replicação viral. / The Zika virus (ZIKV) belongs to the flaviviridae family that includes species transmitted mainly by mosquitoes Aedes sp. In Brazil, cases of fetal microcephaly were associated with ZIKV congenital infection. Several mechanisms of immunoregulation operative during gestation as the inflammation generated and antiviral response are vital for the understanding of congenital ZIKV infection. Thus, it is proposed to evaluate whether inflammation via Toll-like receptor 4 (TLR4-LPS) activation in human and murine placental villi interferes with ZIKV infection. For this, human placental explants of 3rd trimester were activated with LPS and later infected with ZIKV. Our findings show that LPS activation is capable of increasing ZIKV replication in placental villi and elevating the enzymatic activity of lactate dehydrogenase, indicative of cellular activation. Viral replication was inhibited with the treatment of explants with an antioxidant, Naringenin, showing therapeutic potential. LPS placental activation inhibited the IRF-3 pathway, decreasing antiviral activity and increasing protein cleavage of the autophagy pathway component LC3, and these mechanisms may be related to increased viral replication. In parallel, increased production of inflammatory cytokines and Hofbauer cell hyperplasia were detected in inflamed and infected explants, indicating that these fetal macrophages may be a niche for viral replication. In the murine model, we demonstrated that the intravaginal inoculation of LPS in pregnant females prior to infection with ZIKV is able to promote the increase of viral load in the brains of mothers and offspring, with worsening of the microcephaly in fetuses. Together, the data show that in the model of human placental explant and, in vivo, in mice, inflammation is a predisposing factor of ZIKV replication. Immunomodulatory strategies show therapeutic potential, attenuating the inflammatory response and decreasing viral replication.

Nanoparticles, while included in a growing number of consumer products, may pose risks to human health due to heavy metal leaching and/or the production of reactive oxygen species following exposures. Subcellular mechanisms of action triggered as a result of exposure to various nanoparticles are still largely unexplored. In this work, an effort to elucidate such toxicological parameters was accomplished by evaluating oxidative stress generation, changes in gene and protein expression, and cell cycle status after low-dose exposures to a variety of metal and carbon-based nanomaterials in primary human dermal cells. Additionally, mitigation of nanoparticle toxicity via microencapsulation was investigated to assess the feasibility of utilizing nanomaterials in dermally implantable biosensor applications. Cellular immune and inflammatory processes were measured via qPCR and immunoblotting, which revealed gene and protein expression modulation along the NF-kappaB pathway after a variety of nanoparticle exposures. The role of immunoregulatory transcription factor NF-kappaB was examined in an oxidative stress context in cells exposed to a panel of nanoparticles, whereby glutathione conversion and modulation of oxidative stress proteins in normal and NF-kappaB knockdown human dermal fibroblasts were monitored. Results revealed decreased antioxidant response and corresponding increased levels of oxidative stress and cell death in exposed normal cells, compared to NF-kappaB incompetent cells. However, reactive oxygen species production was not an absolute precursor to DNA damage, which was measured by the comet assay, gamma-H2AX expression, and flow cytometry. Protein analysis revealed that map kinase p38, rather than p53, was involved in the halting of the cell cycle in S-phase after ZnO exposures, which caused DNA double strand breaks. Microencapsulation of fluorescent quantum dot nanoparticles, specifically, was utilized as a method to improve system functionality and surrounding cellular viability for the purpose of a dermal analyte detection assay. In vitro results indicated a functional localization of nanoparticles, as well as cessation of cellular uptake. Subsequently, cellular metabolism was unaffected over the range of time and concentrations tested in comparison to unencapsulated quantum dot treatments, indicating the usefulness of this technique in developing nanoparticle-driven biomedical applications.

La protéine IL4I1 est une enzyme sécrétée dont l'activité L-amino acide oxydase vis-à-visde la phénylalanine inhibe la prolifération des lymphocytes T in vitro (Boulland et al, Blood 2007).Comme d'autres enzymes immunosuppressives, elle est exprimée dans les tumeurs au niveau descellules myéloïdes et/ou des cellules tumorales (Carbonnelle-Puscian et al, Leukemia 2009). Le but decette thèse a été de caractériser les conditions d'expression d'IL4I1 et de comprendre son rôle dans lecancer.Nous avons montré que les macrophages et les cellules dendritiques représentent la principalesource d'IL4I1 in vitro et dans des lésions inflammatoires chroniques. L'expression d'IL4I1 dans lesphagocytes mononucléés est induite par les interférons ou les ligands de TLR, activant respectivementSTAT1 et NF-kB, tandis que les lymphocytes B expriment des niveaux nettement plus faibles d'IL4I1sous le contrôle de la voie IL-4/STAT6 et de la voie CD40/NFkB. L'expression d'IL4I1 par des cellulesmonocytaires inhibe la production de cytokines Th1 et pourrait donc contribuer à la régulation del'inflammation Th1 in vivo.Dans un modèle murin de cancer, l'expression d'IL4I1 facilite le développement tumoral endiminuant la réponse T cytotoxique spécifique de la tumeur. Ceci est observé à des niveaux d'activitéIL4I1 proches de ceux mesurés dans des tumeurs humaines, suggérant qu'IL4I1 puisse contribuer àl'échappement des tumeurs au système immunitaire chez l'homme. Nous avons développé plusieursmutants d'IL4I1, afin d'évaluer l'impact de l'activité enzymatique versus celui de l'éventuelle liaison del'enzyme à un récepteur, dans l'effet protumoral observé. Un de ces mutants est actuellementdisponible pour une étude chez la souris.Nos résultats installent définitivement IL4I1 dans le panorama des enzymesimmunosuppressives associées au cancer et ouvrent la voie au développement d'inhibiteursspécifiques comme outils thérapeutiques

This thesis investigated the phytochemistry and pharmacology of immunomodulatory medicinal plant species used traditionally by the Q’eqchi’ Maya Healers Association (QMHA) of Belize, and the Cree of Eeyou Istchee (CEI) of northern Quebec. Using quantitative ethnobotanical methodology, we identified 107 plant species belonging to 49 families used by Q’eqchi’ healers in the treatment of symptoms from 14 usage categories related to inflammation. Regression analysis revealed that the Piperaceae, Araceae, and Begoniaceae are preferentially selected by the Maya. Healer consensus for plant species was high, with 56 species (52%) being used by all the healers, and consensus for usage categories was also high, as informant consensus factor (FIC) values for each category were greater than 0.4. Fifty-two Belizean species were evaluated for their TNF-α inhibitory activity in an LPS-stimulated THP-1 monocyte model. Twenty-one species (40%) demonstrated significant TNF-α inhibition when assayed at 100 µg/mL, 8 of which had greater than 50% of the activity of the parthenolide positive control (10 µg/mL). Significant regressions were found between the anti-inflammatory activity and total healer frequency of use (Fuse) and the use reports for 3 usage categories, which indicated that ethnobotanical parameters can in part predict the activity of traditionally used species. Five sesquiterpene lactones were isolated from the leaves of Neurolaena lobata, one of the most active species tested, all of which demonstrated anti-inflammatory activity greater than that of parthenolide (IC50 = 4.79 µM), with IC50s ranging from 0.17-2.32 µM. Lobatin B was the most active isolate tested. Ethanolic and water extracts of 17 species used by Cree healers were evaluated for their immunomodulatory activity. In general, the average anti-inflammatory activity of ethanolic extracts was 1.8 times greater than that of water extracts, and the pro-inflammatory activity of water extracts was 3.7 times greater than ethanolic extracts. Picea mariana and Pinus banksiana were the most anti-inflammatory ethanolic and water extracts, while the water extract of Sarracenia purpurea was the most pro-inflammatory. Picea marina cones, the most anti-inflammatory Cree medicine, were subjected to bioassay guided isolation. This led to the isolation of the anti-inflammatory lignan (+)-lariciresinol-9’-p-coumarate, which had an IC50 of 28.4 µM. Together, these results validate the traditional knowledge shared by our Q’eqchi’ and Cree collaborators, and draw attention to the therapeutic potential of subtropical and boreal plants as culturally appropriate complements to modern medicine. - Cette thèse porte sur la phytochimie et la pharmacologie des espèces de plantes médicinales immunomodulatrices utilisées traditionnellement par le Q’eqchi’ Maya Healers Association (QMHA) du Belize, et les Cris d'Eeyou Istchee (CEI) du nord du Québec. En utilisant une méthodologie ethnobotanique quantitative, nous avons identifié 107 espèces végétales appartenant à 49 familles utilisées par les guérisseurs Q'eqchi’ dans le traitement de symptômes appartenant à 14 catégories d'utilisation liées à l'inflammation. Une analyse de régression a révélé que les familles Piperaceae, Araceae, et Begoniaceae sont préférentiellement choisis par les Mayas. Le consensus entre guérisseurs pour les espèces végétales était élevé, avec 56 espèces (52%) étant utilisés par tous les guérisseurs, et le consensus pour les catégories d'utilisation était également élevé, car les valeurs de facteur de consensus des informants (FIC) pour chaque catégorie étaient supérieurs à 0,4. Cinquante-deux espèces du Belize ont été évaluées pour leur activité inhibitrice de TNF-α dans un modèle de THP-1 monocytes stimulés par le LPS. Vingt-et-une espèces (40%) ont montré une inhibition significative de TNF-α lorsque dosés à 100 µg/mL, dont 8 d’entre elles ont démontrées plus de 50% de l'activité du contrôle positif parthénolide (10 µg/mL). Des régressions significatives ont été observées entre l'activité anti-inflammatoire et la fréquence d'utilisation de guérisseurs totale (Fuse) et les rapports d'utilisation pour 3 catégories d'utilisation, ce qui indique que les paramètres ethnobotaniques peuvent en partie prédire l'activité des espèces traditionnellement utilisées. Cinq lactones sesquiterpéniques ont été isolés à partir des feuilles de Neurolaena lobata, l'une des espèces les plus actives testées, qui a démontré une activité anti-inflammatoire supérieure à celle du parthénolide (CI50 = 4,79 µM), avec des CI50 allant de 0,17 à 2,32 µM. Lobatin B était l’isolât le plus actif testé. Des extraits éthanoliques et aqueux de 17 espèces utilisées par les guérisseurs Cris ont été évalués pour leur activité immunomodulatrice. En général, l'activité anti-inflammatoire moyenne des extraits éthanoliques était 1,8 fois supérieure à celle des extraits d'eau, et l'activité pro-inflammatoire des extraits d'eau était de 3,7 fois supérieure à celle des extraits éthanoliques. Picea mariana et Pinus banksiana étaient les extraits éthanoliques et aqueux avec le plus d’activité anti-inflammatoire, tandis que l'extrait aqueux de Sarracenia purpurea était le plus pro-inflammatoire. Le cône de Picea marina, le médicament traditionnelle Cris le plus anti-inflammatoire, a été soumis à une isolation guidée par essais biologiques. Cela a mené à l'isolement du lignane anti-inflammatoire (+)-lariciresinol-9'-p-coumarate, qui avait une CI50 de 28,4 µM. Ensemble, ces résultats valident les connaissances traditionnelles partagées par nos collaborateurs Q'eqchi' et Cris, et mettent en évidence le potentiel thérapeutique des plantes subtropicales et boréales comme des compléments à la médecine moderne qui sont culturellement appropriées.